Cargando…

The double-edged roles of ROS in cancer prevention and therapy

Reactive oxygen species (ROS) serve as cell signaling molecules generated in oxidative metabolism and are associated with a number of human diseases. The reprogramming of redox metabolism induces abnormal accumulation of ROS in cancer cells. It has been widely accepted that ROS play opposite roles i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yawei, Qi, Huan, Liu, Yu, Duan, Chao, Liu, Xiaolong, Xia, Tian, Chen, Di, Piao, Hai-long, Liu, Hong-Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978298/ https://www.ncbi.nlm.nih.gov/pubmed/33754031 http://dx.doi.org/10.7150/thno.56747

Ejemplares similares

AQP3‐mediated H(2)O(2) uptake inhibits LUAD autophagy by inactivating PTEN
por: Wang, Yawei, et al.
Publicado: (2021)

A double-edged sword: ROS related therapies in the treatment of psoriasis
por: Hu, Jingyi, et al.
Publicado: (2022)

YB1 regulates miR‐205/200b‐ZEB1 axis by inhibiting microRNA maturation in hepatocellular carcinoma
por: Liu, Xiumei, et al.
Publicado: (2021)

The Role of ROS as a Double-Edged Sword in (In)Fertility: The Impact of Cancer Treatment
por: Mendes, Sara, et al.
Publicado: (2022)

Identification and Characterization of Robust Hepatocellular Carcinoma Prognostic Subtypes Based on an Integrative Metabolite‐Protein Interaction Network
por: Chen, Di, et al.
Publicado: (2021)

Multidirectional characterization of cellular composition and spatial architecture in human multiple primary lung cancers
por: Wang, Yawei, et al.
Publicado: (2023)

Autophagy is a double-edged sword in the therapy of colorectal cancer
por: Zhang, Bo, et al.
Publicado: (2021)

Metabolomic Characterization Reveals ILF2 and ILF3 Affected Metabolic Adaptions in Esophageal Squamous Cell Carcinoma
por: Zang, Bin, et al.
Publicado: (2021)

GPR35 antagonist CID-2745687 attenuates anchorage-independent cell growth by inhibiting YAP/TAZ activity in colorectal cancer cells
por: Otkur, Wuxiyar, et al.
Publicado: (2023)

F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects
por: Tekcham, Dinesh Singh, et al.
Publicado: (2020)

HRD1 inhibits fatty acid oxidation and tumorigenesis by ubiquitinating CPT2 in triple‐negative breast cancer
por: Guo, Xin, et al.
Publicado: (2020)

Antiangiogenic therapy in diabetic nephropathy: A double-edged sword
por: Tao, Qian-Ru, et al.
Publicado: (2021)

A Multidimensional Characterization of E3 Ubiquitin Ligase and Substrate Interaction Network
por: Chen, Di, et al.
Publicado: (2019)

Cellular senescence: a double-edged sword in cancer therapy
por: Xiao, Shuai, et al.
Publicado: (2023)

Emerging roles of extracellular vesicles in COVID‐19, a double‐edged sword?
por: Xia, Xiaohuan, et al.
Publicado: (2021)

Midkine noncanonically suppresses AMPK activation through disrupting the LKB1-STRAD-Mo25 complex
por: Xia, Tian, et al.
Publicado: (2022)

The roles of E3 ubiquitin ligases in cancer progression and targeted therapy
por: Sampson, Chibuzo, et al.
Publicado: (2023)

Case Report: Detection of Double ROS1 Translocations, SDC4-ROS1 and ROS1-GK, in a Lung Adenocarcinoma Patient and Response to Crizotinib
por: Xu, Long, et al.
Publicado: (2021)

Double-Edged Sword of Tumour Suppressor Genes in Schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2019)

Innate lymphoid cells are double‐edged swords under the mucosal barrier
por: Duan, Zhen, et al.
Publicado: (2021)

PPARs: A Double-Edged Sword in Cancer Therapy?
por: Panigrahy, Dipak, et al.
Publicado: (2008)

Electroconvulsive therapy and seizure: a double-edged sword?
por: Shin, Hye-Rim, et al.
Publicado: (2023)

Double-edged sword.
Publicado: (1994)

m6A Modification: A Double-Edged Sword in Tumor Development
por: Gao, Runnan, et al.
Publicado: (2021)

Transcatheter Tricuspid and Mitral Valve Edge-to-Edge Repair: The Double Double Orifice
por: Bechis, Mary Z., et al.
Publicado: (2018)

Inflammasomes in cancer: a double-edged sword
por: Kolb, Ryan, et al.
Publicado: (2014)

Free Radicals as a Double-Edged Sword: The Cancer Preventive and Therapeutic Roles of Curcumin
por: Gupta, Nehal, et al.
Publicado: (2020)

Autophagy, a double-edged sword in hepatocarcinogenesis
por: Tian, Yongjun, et al.
Publicado: (2015)

Ferroptosis: A Double-Edged Sword in Gastrointestinal Disease
por: Xu, Chengfei, et al.
Publicado: (2021)

Regulated necrosis in COVID-19: A double-edged sword
por: Sun, Chen, et al.
Publicado: (2022)

The double-edged sword effects of differential leadership on deviant behavior
por: Liu, Yingyan, et al.
Publicado: (2022)

The double-edged role of hydrogen sulfide in the pathomechanism of multiple liver diseases
por: Liu, Bihan, et al.
Publicado: (2022)

Insight into the Double-Edged Role of Ferroptosis in Disease
por: Zhang, Lei, et al.
Publicado: (2021)

Antiplatelet therapy: a double-edged sword in head injury?
por: Beynon, Christopher, et al.
Publicado: (2013)

Fluid Therapy: Double-Edged Sword during Critical Care?
por: Benes, Jan, et al.
Publicado: (2015)

Macrophages in Glioblastoma Development and Therapy: A Double-Edged Sword
por: Wu, Mengwan, et al.
Publicado: (2022)

MSCs can be a double-edged sword in tumorigenesis
por: Zhang, Lu, et al.
Publicado: (2022)

Autophagy plays a double-edged sword role in liver diseases
por: Zhou, Jing-chao, et al.
Publicado: (2021)

A game theory-based COVID-19 close contact detecting method with edge computing collaboration
por: Shen, Yue, et al.
Publicado: (2023)

Double‐Edged Role of Resource Competition in Gene Expression Noise and Control
por: Goetz, Hanah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o45a0ok3usidj6ipj211of87mk